Babag, Arriane B.
HRN: 26-00-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2024
MUPIROCIN 2%, 15G (TUBE)
10/13/2024
10/20/2024
TOPICAL
As Needed
TID
Phlebitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes